Evaluating biomarkers in metastatic castration-resistant prostate cancer patients treated with enzalutamide: PSA, circulating tumor cell counts, AR-V7 status and radiographic progression.

Shruti U. Gandhy, Ravi A. Madan, Jennifer L. Marté et al.|Journal of Clinical Oncology|2020

Cited by 1